Global Nuclear Medicine/Radiopharmaceutic Sales Market Report 2018 by Manufacturer, Region, Type and Application

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Nuclear Medicine/Radiopharmaceutic Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Diagnostic Market Performance (Volume)
  • 2.1.2 Therapeutic Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Diagnostic Market Performance (Value)
  • 2.1.2 Therapeutic Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Oncology Market Performance (Volume)
  • 3.1.2 Thyroid Market Performance (Volume)
  • 3.1.3 Cardiology Market Performance (Volume)
  • 3.1.4 Others Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 China Isotope Radiation
  • 4.1.1 China Isotope Radiation Profiles
  • 4.1.2 China Isotope Radiation Product Information
  • 4.1.3 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Business Performance
  • 4.1.4 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Business Development and Market Status
• 4.2 Dongcheng
  • 4.2.1 Dongcheng Profiles
  • 4.2.2 Dongcheng Product Information
  • 4.2.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Business Performance
  • 4.2.4 Dongcheng Nuclear Medicine/Radiopharmaceutic Business Development and Market Status
• 4.3 Jaco
  • 4.3.1 Jaco Profiles
  • 4.3.2 Jaco Product Information
  • 4.3.3 Jaco Nuclear Medicine/Radiopharmaceutic Business Performance
  • 4.3.4 Jaco Nuclear Medicine/Radiopharmaceutic Business Development and Market Status
• 4.4 Ciaeriar
  • 4.4.1 Ciaeriar Profiles
  • 4.4.2 Ciaeriar Product Information
  • 4.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceutic Business Performance
  • 4.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceutic Business Development and Market Status
• 4.5 Advanced Molecular-imaging Solution
  • 4.5.1 Advanced Molecular-imaging Solution Profiles
  • 4.5.2 Advanced Molecular-imaging Solution Product Information
  • 4.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Business Performance
  • 4.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Business Development and Market Status
• 4.6 Shanghai Atom Kexing
  • 4.6.1 Shanghai Atom Kexing Profiles
  • 4.6.2 Shanghai Atom Kexing Product Information
  • 4.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Business Performance
  • 4.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Business Development and Market Status
• 4.7 Cardinal Health
  • 4.7.1 Cardinal Health Profiles
  • 4.7.2 Cardinal Health Product Information
  • 4.7.3 Cardinal Health Nuclear Medicine/Radiopharmaceutic Business Performance
  • 4.7.4 Cardinal Health Nuclear Medicine/Radiopharmaceutic Business Development and Market Status
• 4.8 Mallinckrodt
  • 4.8.1 Mallinckrodt Profiles
  • 4.8.2 Mallinckrodt Product Information
  • 4.8.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Business Performance
  • 4.8.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Business Development and Market Status
• 4.9 GE Healthcare
  • 4.9.1 GE Healthcare Profiles
  • 4.9.2 GE Healthcare Product Information
  • 4.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Business Performance
  • 4.9.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Business Development and Market Status
• 4.10 Lantheus Medical Imaging
  • 4.10.1 Lantheus Medical Imaging Profiles
  • 4.10.2 Lantheus Medical Imaging Product Information
  • 4.10.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Business Performance
  • 4.10.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Business Development and Market Status
• 4.11 Bayer Healthcare
• 4.12 Bracco Imaging
• 4.13 Jaco
• 4.14 Ciaeriar
• 4.15 Advanced Molecular-imaging Solution

5 Market Performance for Manufacturers

• 5.1 Global Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Nuclear Medicine/Radiopharmaceutic Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Nuclear Medicine/Radiopharmaceutic Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 China Market Performance for Manufacturers
  • 6.1.1 China Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 China Nuclear Medicine/Radiopharmaceutic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 China Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 China Nuclear Medicine/Radiopharmaceutic Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 USA Market Performance for Manufacturers
  • 6.2.1 USA Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 USA Nuclear Medicine/Radiopharmaceutic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 USA Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 USA Nuclear Medicine/Radiopharmaceutic Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 Europe Market Performance for Manufacturers
  • 6.3.1 Europe Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 Europe Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 Europe Nuclear Medicine/Radiopharmaceutic Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Japan Market Performance for Manufacturers
  • 6.4.1 Japan Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Japan Nuclear Medicine/Radiopharmaceutic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Japan Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Japan Nuclear Medicine/Radiopharmaceutic Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Korea Market Performance for Manufacturers
  • 6.5.1 Korea Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Korea Nuclear Medicine/Radiopharmaceutic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Korea Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Korea Nuclear Medicine/Radiopharmaceutic Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 India Market Performance for Manufacturers
  • 6.6.1 India Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 India Nuclear Medicine/Radiopharmaceutic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 India Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 India Nuclear Medicine/Radiopharmaceutic Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Southeast Asia Market Performance for Manufacturers
  • 6.7.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Southeast Asia Nuclear Medicine/Radiopharmaceutic Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 South America Market Performance for Manufacturers
  • 6.8.1 South America Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 South America Nuclear Medicine/Radiopharmaceutic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 South America Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 South America Nuclear Medicine/Radiopharmaceutic Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Global Nuclear Medicine/Radiopharmaceutic Market Performance (Sales Point)

• 7.1 Global Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Global Nuclear Medicine/Radiopharmaceutic Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Global Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) by Regions 2013-2018
• 7.4 Global Nuclear Medicine/Radiopharmaceutic Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 China Nuclear Medicine/Radiopharmaceutic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 USA Nuclear Medicine/Radiopharmaceutic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 Europe Nuclear Medicine/Radiopharmaceutic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Japan Nuclear Medicine/Radiopharmaceutic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Korea Nuclear Medicine/Radiopharmaceutic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 India Nuclear Medicine/Radiopharmaceutic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Oncology Industry
• 11.2 Thyroid Industry
• 11.3 Cardiology Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 China Nuclear Medicine/Radiopharmaceutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 USA Nuclear Medicine/Radiopharmaceutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 Europe Nuclear Medicine/Radiopharmaceutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Japan Nuclear Medicine/Radiopharmaceutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Korea Nuclear Medicine/Radiopharmaceutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 India Nuclear Medicine/Radiopharmaceutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 South America Nuclear Medicine/Radiopharmaceutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Diagnostic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Therapeutic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Oncology Sales and and Growth Rate 2019-2024
  • 12.4.3 Thyroid Sales and and Growth Rate 2019-2024
  • 12.4.4 Cardiology Sales and and Growth Rate 2019-2024
  • 12.4.5 Others Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Global Nuclear Medicine/Radiopharmaceutic Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Global Nuclear Medicine/Radiopharmaceutic Gross Profit Trend 2019-2024

13 Conclusion